Swiss pharma company Roche is buying Flatiron Health for $1.9 billion
Roche, the global pharmaceutical company from Switzerland, today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors, in a $1.9 billion deal. Flatiron has also confirmed the deal to TechCrunch. Read More
Sign in to read full story
In order for you to continue reading the full contents of the post, you will need to login first
